Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation.

Draper B, Yee WL, Bowring A, Naing W, Kyi KP, Htay H, Howell J, Hellard M, Pedrana A.

Global Infectious Disease Threats Hepatitis C

The National Naloxone Reference Group: A collective voice on take-home naloxone policy and practice in Australia.

Dietze P, Stewart A, Hill P, Draper B, Curtis M, Kirwan A, National Naloxone Reference Group

Alcohol and Other Drugs Injecting Drug Use

The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia.

Gunn J, O'Keefe D, Draper BL, Djordjevic F, Ryan K, Kerr P, Elsum I, Gold J, Layton C, Chan K, Dietze P, Higgs P, Doyle J, Stoové MA, Hellard M, Pedrana A

Patients' access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study.

Yee WL, Bowring A, Draper B, O'Keefe D, Htay H, Myint KT, Aung HWP, Win YY, Sein YY, Mary M, Lin A, Pedrana A, Hellard M

Hepatitis C

Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study.

Yee WL, Draper B, Myint KT, Min W, Htay H, O'Keefe D, Hellard M

Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up.

Draper BL, Yee WL, Shilton S, Bowring A, Htay H, Nwe N, Markby J, Kyi KP, Easterbrook P, Naing W, Win TM, Aung KS, Howell J, Pedrana A, Hellard M